The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. Saal J, Eckstein M, Ritter M, Brossart P, et al. Eur J Cancer 2025;215:115163.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saal J, Eckstein M, Ritter M, Brossart P, et al. The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. Eur J Cancer 2025;215:115163.
PMID: 39662097